Medifast Announces Fourth Quarter and Full Year 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Medifast (MED) PT Lowered to $16.50 at DA Davidson
February 19, 2025 1:01 PM ESTDA Davidson analyst Linda Bolton Weiser lowered the price target on Medifast (NYSE: MED) to $16.50 (from $17.00) while maintaining a Neutral rating.
The analyst comments "NEUTRAL-rated MED reported a 4Q24 beat. In December, it launched the Ascend line for people who were... More
Medifast (MED) Tops Q4 EPS by 24c, Misses on Revenue; Offers Q1 Revenue Guidance
February 18, 2025 4:10 PM ESTMedifast (NYSE: MED) reported Q4 EPS of $0.10, $0.24 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $119 million versus the consensus estimate of $131.65 million.
GUIDANCE:
Medifast sees Q1 2025 revenue of $100-120 million, versus the consensus of $130.75... More
